A crucial step in preclinical drug development is the confirmation of the novel therapeutic molecule's specific binding to the targeted protein. Transmembrane proteins (TPs) like ion channels, ...
In this interview, Dr. Fang-Yi Chu talks to NewsMedical about the role of transmembrane proteins in targeting oncology research. Can you explain what transmembrane proteins are and why they are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback